It has been estimated that there are at least 40 proteins participating in this pathway, but it was the recognition that this included BRCA1 and BRCA2 that provided the stimulus to study this pathway in breast and ovarian cancer. The gene discussed is BRCA2; the disease is ovarian carcinoma.